Clinical Trials Directory

Trials / Unknown

UnknownNCT06325501

Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

The Efficacy Of Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
56 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
20 Years – 48 Years
Healthy volunteers
Not accepted

Summary

Uterine leiomyomas, or fibroids, are common benign tumors among women, especially those over 35 years old. They can cause various issues, including heavy menstrual bleeding, anemia, pelvic pain, and pressure symptoms. Surgery is often necessary for symptomatic fibroids, with hysterectomy recommended for women over 40 and myomectomy for those wishing to preserve their uterus. Myomectomy can be performed using different surgical approaches but can be associated with significant morbidity, particularly major blood loss, especially in abdominal myomectomy, where up to 20% of women may require blood transfusion. Various interventions have been introduced to reduce bleeding during myomectomy, such as tourniquets, bupivacaine plus epinephrine infiltration, vasopressin injection, preoperative GnRH agonist administration, and preoperative ascorbic acid injection. However, these strategies may have complications, be ineffective, expensive, or require extra steps. Oxytocin, primarily secreted from the pituitary gland, is crucial for uterine contraction during labor and delivery, and is used to prevent postpartum uterine atony and bleeding. However, caution is needed in its use, especially in women with heart disease or hypovolemia. Misoprostol, a prostaglandin E1 analogue, can reduce bleeding during myomectomy by promoting myometrial contractions and reducing uterine artery blood flow. It can be administered via multiple routes, with rectal administration showing advantages in maintaining high plasma concentrations during surgery. Studies have investigated the effectiveness of single preoperative rectal doses of misoprostol versus preoperative oxytocin in reducing bleeding during abdominal myomectomy.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostol 200mcg Tabreceiving a preoperative rectal dose of 800 ug of misoprostol half an hour before surgery
DRUGOxytocinafter the induction of general anaesthesia (GA), an infusion of 40 IU oxytocin in 500 ml normal saline was started at the rate of 250 ml/hour

Timeline

Start date
2024-03-01
Primary completion
2024-12-01
Completion
2025-01-01
First posted
2024-03-22
Last updated
2024-03-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06325501. Inclusion in this directory is not an endorsement.